Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Med Mushrooms ; 21(11): 1123-1136, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-32450022

RESUMEN

The present study evaluates the antiarthritic effect of hydroethanolic extract of Pleurotus ostreatus cv. Florida, which was tested against adjuvant induced arthritis in rat models. Arthritis was induced by administration of complete Freund's adjuvant into the subplantar surface of left paw of rats. The extract was given orally at doses 200 mg/ kg and 400 mg/kg and piroxicam was administered intraperitonially (4 mg/kg). In vitro testing on parameters including antiproteinestrase, albumin denaturation and heat induce hemolysis was also carried out. There was significant decrease (p < 0.001) in proteinase activity and membrane stabilization in vivo studies on cv. Florida extract treated rats showed a significant (p < 0.001) decrease in paw volume, joint diameter, and spontaneous change in body weight recorded for 21 days. The treatment also resulted in an increase in rats' gripping activity compared with arthritic control rats. X-ray examinations showed a decrease in joint swelling. Histopathological examination of the extract treated group showed a significant decrease in joint space. There was also an increase in antibody levels. The antioxidant parameters showed a significant (p < 0.001) increase in superoxide dismutase and catalase enzymatic activities. Thus P. ostreatus cv. Florida extract demonstrates a potent antioxidant activity in a rat model. It is concluded that the P. ostreatus cv. Florida extract contains medicinally important constituents that show antiarthritic activity in rats.


Asunto(s)
Antiinflamatorios/administración & dosificación , Artritis/terapia , Terapia Biológica/métodos , Mezclas Complejas/administración & dosificación , Pleurotus/química , Adyuvantes Inmunológicos/administración & dosificación , Administración Oral , Animales , Antiinflamatorios/aislamiento & purificación , Artritis/inducido químicamente , Artritis/patología , Peso Corporal , Mezclas Complejas/aislamiento & purificación , Modelos Animales de Enfermedad , Adyuvante de Freund/administración & dosificación , Histocitoquímica , Inyecciones Intraperitoneales , Piroxicam/administración & dosificación , Ratas , Resultado del Tratamiento
2.
J Diet Suppl ; 13(6): 607-15, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27027824

RESUMEN

Amaranthus cruentus (Amaranthaceae) is one of the popularly grown leafy vegetables in the Indian subcontinent. Leaves of the plant are rich in polyphenols, tannins, flavonoids, steroids, terpenoids, saponins, and betalains. The plant also contains rich amounts of protein, calcium, iron, vitamins A, E, and C, and folic acid. The present work was undertaken to evaluate the antianemic effect of Amaranthus cruentus. Ethanol extract of Amaranthus cruentus was prepared. Acute oral toxicity of the extract was determined by Organization for Economic Cooperation and Development (OECD) Guideline 423. Doses of 200 and 400 mg/kg were used in the present study. Phenylhydrazine (60 mg/kg, intraperitoneal injection for three consecutive days) was used to induce anemia in rats. After anemia induction, animals were treated with standard preparation and extract. Amaranthus cruentus extract significantly aided in restoring the levels of red blood cells, white blood cells (WBCs), and hemoglobin. There was also an increase in hematocrit. Thus, it can be concluded that Amaranthus cruentus is a rich source of phytochemicals that are responsible for demonstrating hematopoietic effects. Isolation and structure elucidation of constituents, responsible for antianemic activity, is necessary to affirm the aforementioned effect.


Asunto(s)
Amaranthus/química , Hematopoyesis/efectos de los fármacos , Fenilhidrazinas/toxicidad , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Anemia/inducido químicamente , Anemia/tratamiento farmacológico , Animales , Recuento de Eritrocitos , Hematócrito , Hemoglobinas/análisis , Recuento de Leucocitos , Fitoterapia , Ratas
3.
Indian J Pharmacol ; 47(4): 394-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26288471

RESUMEN

OBJECTIVES: Wheat grass (Triticum aestivum) is a gift of nature given to mankind. A number of scientific research on wheatgrass establishes its anticancer and antioxidant potential. Current work was focused to determine antileukemic effect of wheat grass. MATERIALS AND METHODS: The commercial wheatgrass powder was extracted with 95% of methanol. Methanol extract of wheat grass was studied for acute oral toxicity as per revised Organization for Economic Cooperation and Development Guidelines number 423. Leukemia was successfully induced in Wister rats by intravenous injection of benzene. The blood was collected and analyzed for hematological parameters. Phagocytotic activity of the extract was determined. RESULTS: Phytochemical screening revealed the presence of flavonoids, phenolics, carbohydrates, and amino acids. From acute toxicity studies, it was found that the methanol extract of wheatgrass was safe up to a dose level of 2000 mg/kg of body weight. Outcomes of hematological parameters in various experimental groups of murine model demonstrated antileukemic effect of extract. Methanol extract of wheatgrass aroused the process of phagocytosis of killed Candida albicans and also demonstrated a significant chemotactic activity at all tested concentrations. CONCLUSION: In the current work, methanol extract of wheat grass demonstrated antileukemic potential that might be due to the presence of flavonoids and polyphenolics in it. Further isolation, structural characterization of active constituents is necessary to extrapolate the mechanism of action.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Leucemia/prevención & control , Extractos Vegetales/farmacología , Triticum/química , Animales , Antineoplásicos Fitogénicos/administración & dosificación , Benceno/toxicidad , Femenino , Masculino , Extractos Vegetales/administración & dosificación , Hipofraccionamiento de la Dosis de Radiación , Ratas , Ratas Wistar , Pruebas de Toxicidad Aguda
4.
Indian J Pharmacol ; 47(1): 86-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25821317

RESUMEN

AIM: The severity of adverse reactions due to antiepileptics is observed during initiation and early treatment in which impairment of cognitive effects are common. Since long time, herbal medicine is a natural remedy to treat neural symptoms. Phytochemicals have been proven to be potent neuro-protective agents. Rutin, a bioflavonoid is established to be nootropic in many studies. In this study, we aimed to determine the protective effect of rutin in zebrafish against the side effects produced by AEDs. MATERIALS AND METHODS: Seizures were induced in zebrafish by phenylenetetrazole. Rutin pretreatment (50 mg/kg, single injection, i.p.) was done before commencement of the study. Behavioral studies were performed as: latency to move high in the tank, locomotion effects, color effect, shoal cohesion, light/dark test on Zebrafish. RESULTS: Treatment with rutin reverted the locomotor behavior to normal. Treatment with AEDs caused fishes to move in all regions while, in case of treatment with rutin, the response reverted to normal. Treatment with AEDs altered swimming behavior of zebrafish, however, rutin showed a positive effect over this behavior. Treatment with AEDs resulted in restricted movement of zebrafish to the dark zone. Treatment with rutin caused increased latency of zebrafish to move in the light compartment. Similarly, time spent in the light compartment by zebrafish treated with rutin was significantly (P < 0.01) higher as compared to zebrafish treated with AEDs. CONCLUSION: The results suggest a protective role of rutin on cognition impaired by AEDs.


Asunto(s)
Anticonvulsivantes/toxicidad , Conducta Animal/efectos de los fármacos , Trastornos del Conocimiento/prevención & control , Cognición/efectos de los fármacos , Rutina/farmacología , Convulsiones/prevención & control , Animales , Trastornos del Conocimiento/inducido químicamente , Trastornos del Conocimiento/psicología , Modelos Animales de Enfermedad , Actividad Motora/efectos de los fármacos , Pentilenotetrazol , Tiempo de Reacción/efectos de los fármacos , Convulsiones/inducido químicamente , Conducta Social , Natación , Factores de Tiempo , Pez Cebra
5.
Interdiscip Toxicol ; 8(2): 99-102, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27486367

RESUMEN

Drug induced nephrotoxicity is one of the most common causes of renal failure. Gentamicin belongs to aminoglycosides, which elicit nephrotoxic potential. Natural antioxidants from plants demonstrate a number of biotherapeutic activities. Coriander is an important medicinal plant known for its hepatoprotective, diuretic, carminative, digestive and antihelminthic potential. This study was designed to investigate whether the extract of Coriandrum sativum ameliorates the nephrotoxicity induced by gentamicin in rats. Dried coriander powder was coarsely grinded and subjected to defatting by petroleum ether and further with ethyl acetate. The extract was filtered and subjected to phytochemical and phytoanalytical studies. Acute toxicity in Wistar rats was determined by the OECD Guideline (423). Animals were divided into four groups. The first group served as positive control, while the second group was toxic control (gentamicin treated). The third and fourth group were treated with the extract (200 and 400 mg/kg gentamicin). After 8 days, the animals were sacrificed and biochemical and histopathological studies were carried out. Phytochemical screening of the extract demonstrated Coriandrum sativum to be rich in flavonoids, polyphenolics and alkaloids. Results of acute toxicity suggested the use of 200 mg/kg and 400 mg/kg for Coriandrum sativum in the study. Coriandrum sativum extract at the dose of 400 mg/kg significantly (p<0.01) decreased creatinine levels in the animals, along with a decrease in serum urea and blood urea nitrogen. Treatment with Coriandrum sativum extract ameliorated renal histological lesions. It is concluded that Coriandrum sativum is a potential source of nephroprotective phytochemical activity, with flavonoids and polyphenols as the major components.

6.
Drug Deliv ; 22(1): 94-9, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24491122

RESUMEN

BACKGROUND: Acetic acid ulcerative colitis (UC) is an experimental condition created due to intra-rectal administration of acetic acid which causes inflammation and ulceration in the lining of colon and rectum. In such condition, the colon cannot absorb liquid from the stools, resulting in larger volume of watery stools. Mesalazine is mainly used for the treatment of UC but suffers from the drawback of having poor bioavailability. UC is also characterized by alteration in colonic microflora. The present work was focused on delivering mesalazine along with probiotic, which would facilitate to refurbish customary growth of microflora. Mesalazine and probiotic were encapsulated in pectin beads with an aim to protect the drug from gastric environment and target to colonic region. METHODS: Pectin beads were prepared, formulation process was optimized for polymer concentration, drug concentration, cross-linking agent concentration. Formulation was characterized for surface morphology, in vitro drug release studies, determination of viable cell count, in vivo ulcer protective studies and stability studies. RESULTS: Average particle diameter of beads was ∼1.44-1.72 mm. Drug entrapment efficiency was found to be optimal (78-79%). A sustained release of drug was observed for 5 h; nearly 60% of drug was released at the end of 10 h. Microbiological studies of probiotic showed best cell viability. In acetic acid induced UC model, Mesalazine-probiotic beads-treated group showed significant (p < 0.01) ulcer protection index with respect to free drug-treated group. CONCLUSION: In conclusion, mesalazine-probiotic loaded beads may serve as a useful colon specific drug delivery system for treatment of colitis.


Asunto(s)
Colitis Ulcerosa/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Mesalamina/administración & dosificación , Probióticos/administración & dosificación , Ácido Acético/toxicidad , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/farmacología , Supervivencia Celular/efectos de los fármacos , Colitis Ulcerosa/patología , Colon/metabolismo , Colon/patología , Preparaciones de Acción Retardada , Modelos Animales de Enfermedad , Portadores de Fármacos/química , Liberación de Fármacos , Masculino , Mesalamina/farmacología , Tamaño de la Partícula , Pectinas/química , Probióticos/farmacología , Ratas , Ratas Wistar
7.
Indian J Pharmacol ; 46(1): 109-12, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24550595

RESUMEN

OBJECTIVE: The current work was aimed to evaluate the nephroprotective potential of Butea monosperma. MATERIALS AND METHODS: Butea monosperma was collected from local forest of Jabalpur and extracted with ethanol. Healthy adult male Wistar albino rats between 5 and 6 months of age and weighing about 150-200 g were used for the study. Acute toxicity studies were performed to determine dose of extract. Nephrotoxicity was induced by gentamicin. Animals were divided in four groups in which first group served as positive control, second group as gentamicin treated toxic control; animals of group three and four were treated with Butea monosperma extract. Extract was administered to animals via oral route. Serum creatinine, serum urea, and blood urea nitrogen were estimated. Body weight was also determined. Histopathological studies were performed to access gross anatomical changes in animals. RESULTS: The extract of Butea monosperma was found to be rich in flavonoids, polyphenolics, and alkaloids. Urine creatinine, serum urea, and blood urea nitrogen were found to be significantly (P < 0.001) increased in rats treated with only gentamicin; whereas, treatment with the ethanolic extract of leaf of Butea monosperma reversed the effect of gentamicin indicating nephroprotective activity. CONCLUSION: The present study revealed that ethanolic extract of Butea monosperma is a good source of phytochemicals. The phytoconstituents flavonoids, phenolics, and alkaloids present in the extracts may be responsible for antioxidant activity. By the virtue of antioxidant activity, Butea monosperma demonstrated nephroprotective activity.


Asunto(s)
Butea/química , Riñón/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Evaluación Preclínica de Medicamentos , Gentamicinas/efectos adversos , Masculino , Ratas , Ratas Wistar
8.
Indian J Ophthalmol ; 62(2): 154-7, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24008789

RESUMEN

AIM OF STUDY: The aim of current work was to evaluate in vitro anticataract potential of Moringa oliefera extract. MATERIALS AND METHODS: Goat eye lenses were divided into 4 groups; Group served as control, Group II as toxic control, Group III and Group IV were incubated in extract (250 µg/ml and 500 µg/ml of extract of M. oliefera) Group II, III and IV were incubated in 55 mM glucose in artificial aqueous humor to induce lens opacification. Estimation of total, water soluble protein, catalase, glutathione and malondialdehyde along with photographic evaluation of lens was done. RESULTS: Group II (toxic control) lenses showed high amount of MDA (Malondialdehyde), soluble, insoluble protein, decreased catalase and glutathione levels, while lenses treated with Moringa oliefera extract (Group III and Group IV) showed significant (FNx01 P < 0.05) reduction in MDA and increased level of catalase, glutathione, total and soluble protein. CONCLUSION: Results of present findings suggest protective effect of Moringa oliefera in prevention of in vitro glucose induced cataract.


Asunto(s)
Catarata/prevención & control , Etanol/farmacología , Cristalino/efectos de los fármacos , Moringa oleifera , Extractos Vegetales/uso terapéutico , Animales , Catarata/inducido químicamente , Catarata/patología , Modelos Animales de Enfermedad , Glucosa/toxicidad , Cabras , Cristalino/patología , Solventes/farmacología
9.
Drug Deliv ; 19(3): 132-42, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22428685

RESUMEN

PURPOSE: Neuroendocrine tumors often present a diagnostic and therapeutic challenge. We have aimed to synthesize and develop biodegradable nanoparticles of somatostatin analogue, octreotide for targeted therapy of human neuroendocrine pancreatic tumor. METHODS: Direct solid phase peptide synthesis of octreotide was done. Octreotide loaded PCL/PEG nanoparticles were prepared by solvent evaporation method and characterized for transmission electron microscopy, differential scanning calorimetery (DSC), Zeta potential measurement studies. The nanoparticles were evaluated in vitro for release studies and peptide content. For biological evaluations, receptor binding & cytotoxicity studies were done on BON-1 neuroendocrine tumor cell line. Biodistribution of radiolabeled peptide and nanoparticles, tumor regression studies were performed on tumor-bearing mouse models. RESULTS: We have synthesized and purified octreotide with the purity of 99.96% in our laboratory. PEG/PCL nanoparticles with an average diameter of 130-195 nm having peptide loading efficiency of 66-84% with a negative surface charge were obtained with the formulation procedure. Octreotide nanoparticles have a negative action on the proliferation of BON-1 cells. In vivo biodistribution studies exhibited major accumulation of octreotide nanoparticles in tumor as compared to plain octreotide. Octreotide nanoparticles inhibited tumor growth more efficiently than free octreotide. CONCLUSIONS: Thus, it was concluded that the PCL/PEG nanoformulation of octreotide showed high tumor uptake due to the enhanced permeation and retention (EPR) effect and then peptide ligand imparts targetability to the sst2 receptor and there by showing increase tumor growth inhibition. Selective entry of nanoparticles to the tumor also give the reduce side effects both in vivo and in vitro.


Asunto(s)
Sistemas de Liberación de Medicamentos , Óxido de Etileno/administración & dosificación , Lactonas/administración & dosificación , Nanopartículas/administración & dosificación , Tumores Neuroendocrinos/tratamiento farmacológico , Octreótido/administración & dosificación , Técnicas de Síntesis en Fase Sólida , Animales , Línea Celular Tumoral , Sistemas de Liberación de Medicamentos/métodos , Evaluación Preclínica de Medicamentos/métodos , Óxido de Etileno/metabolismo , Humanos , Lactonas/metabolismo , Ratones , Ratones Endogámicos BALB C , Tumores Neuroendocrinos/metabolismo , Octreótido/análogos & derivados , Octreótido/metabolismo , Técnicas de Síntesis en Fase Sólida/métodos , Somatostatina/administración & dosificación , Somatostatina/análogos & derivados , Somatostatina/metabolismo , Ensayos Antitumor por Modelo de Xenoinjerto/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA